首页> 外文期刊>Japanese Journal of Cancer Research >In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions.
【24h】

In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions.

机译:原位mRNA杂交技术用于分析胃癌前病变和癌病变中的人类端粒酶RNA。

获取原文
获取原文并翻译 | 示例
           

摘要

Telomerase, the ribonucleoprotein enzyme that elongates telomerase, is repressed in normal somatic cells but is reactivated during tumor progression. The purpose of this study was to investigate the localization of human telomerase RNA (hTR) expression in human gastric precancerous and cancerous lesions by using in situ mRNA hybridization (ISH) with avidin-biotin staining. We also examined telomerase activity in these lesions by using hybridization protection assay connected with a telomeric repeat amplification protocol (TRAP/HPA). Analyzed tissue samples were as follows; 132 cases of chronic atrophic gastritis without intestinal metaplasia, 115 incomplete-type intestinal metaplasias, 40 complete-type intestinal metaplasias, 23 hyperplastic polyps, 23 tubular adenomas and 26 adenocarcinomas. In ISH analysis, high levels of hTR expression were observed preferentially in the nuclei at the single-cell level. hTR-expressing cells in carcinomas and adenomas were significantly more frequent than those of the other lesions (P < 0.001). The expression pattern of hTR in carcinoma and adenoma tissues was heterogeneous and similar intratumor heterogeneity was detected in Ki-67 immunoreactivity. Infiltrating lymphocytes in tissue also exhibited high levels of hTR expression. In TRAP/HPA analysis, carcinomas had significantly more frequent positivity for telomerase activity and a higher level of telomerase activity than the other lesions (P < 0.05). However, the amount of telomerase activity did not parallel the expression level of hTR. Our data suggest that hTR expression increases in the early stages of stomach carcinogenesis and that sufficient synthesis of hTR is a prerequisite for telomerase reactivation in tumorigenesis.
机译:端粒酶是延长端粒酶的核糖核蛋白酶,在正常的体细胞中被抑制,但在肿瘤进展过程中被重新激活。这项研究的目的是通过使用亲和素-生物素染色的原位mRNA杂交(ISH)研究人端粒酶RNA(hTR)在人胃癌前病变和癌性病变中的表达定位。我们还通过使用与端粒重复扩增方案(TRAP / HPA)连接的杂交保护测定法检查了这些病变中的端粒酶活性。分析的组织样品如下。 132例无肠化生的慢性萎缩性胃炎,115例不完全型肠化生,40例完全型肠化生,23例增生性息肉,23例肾小管腺瘤和26例腺癌。在ISH分析中,优先在单细胞水平的细胞核中观察到高水平的hTR表达。癌和腺瘤中表达hTR的细胞比其他病变中的频率显着更高(P <0.001)。 hTR在癌和腺瘤组织中的表达模式是异质的,并且在Ki-67免疫反应性中检测到相似的肿瘤内异质性。组织中的浸润淋巴细胞也表现出高水平的hTR表达。在TRAP / HPA分析中,与其他病变相比,癌症对端粒酶活性的阳性率明显更高,并且端粒酶活性的水平更高(P <0.05)。但是,端粒酶活性的量并不与hTR的表达水平平行。我们的数据表明hTR表达在胃癌发生的早期阶段增加,并且hTR的充分合成是端粒酶在肿瘤发生中重新激活的先决条件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号